The Tsetis Group of Pharmaceutical Companies (OFET) is a solid reference point for the pharmaceutical and health environment, providing pioneering products placing the group’s companies amongst the most reliable ambassadors of high quality health care.

Established in 1964, UNI-PHARMA S.A.’s primary scope is the development and production of innovative, value adding products to improve the Quality of Life and is a market leader in Levothyroxine sodium, low-dose ASA and IV Paracetamol.

Established in 1996 INTERMED S.A. is specialized in high standard innovative health care products, exploring future prospects in international scientific developments, constantly expanding its product portfolio covering all major healthcare categories.